Transverse Myelitis Market is Projected to grow at a CAGR of 3.2% during period 2019-2023

About This Presentation
Title:

Transverse Myelitis Market is Projected to grow at a CAGR of 3.2% during period 2019-2023

Description:

Transverse myelitis is a neurological disorder caused due to the inflammation across both sides of one segment of the spinal cord. – PowerPoint PPT presentation

Number of Views:3

less

Transcript and Presenter's Notes

Title: Transverse Myelitis Market is Projected to grow at a CAGR of 3.2% during period 2019-2023


1
Transverse Myelitis Market is Projected to grow
at a CAGR of 3.2 during period 2019-2023
SAMPLE
FOR MORE INFO
2
Transverse Myelitis Market
Market Highlights Transverse myelitis is a
neurological disorder caused due to the
inflammation across both sides of one segment of
the spinal cord. This disorder can occur in any
age and sex, but female patients are at higher
risk of having transverse myelitis. The causes of
transverse myelitis include infections, immune
system disorders, and other disorders that may
damage or destroy myelin, the fatty white
insulating substance covering the nerve cell
fibers. The increasing prevalence of transverse
myelitis (TM), growing prevalence of diseases
which can lead to transverse myelitis such as
viral infections and some types of cancers,
rising in research and development activities,
and increasing expenditure on healthcare sector
by the government in developed as well as
developing countries is anticipated to propel the
global transverse myelitis market. According to
the National Institute of Neurological Disorders
and Stroke, it is estimated that about 1,400 new
cases of transverse myelitis (TM) are diagnosed
each year in the US. However, high cost
associated with the diagnosis and treatment of
transverse myelitis can hamper the growth of the
market over the assessment period Request For
Sample Report https//www.marketresearchfuture.co
m/sample_request/6490
3
Transverse Myelitis Market
Regional Analysis The market in the Americas is
expected to dominate the global transverse
myelitis market during the forecast period owing
to the presence of a well-established healthcare
system, increasing healthcare expenditure, and
the growing prevalence of transverse
myelitis. The European market is expected to be
the second-largest due to government funding and
support of the healthcare sector coupled with the
rising prevalence of transverse myelitis.
Moreover, the market in Asia-Pacific is
anticipated to be the fastest-growing during the
assessment period owing to a rising number of
rare diseases and continuously developing
healthcare infrastructure. Additionally,
increased funding in the research activities by
pharmaceutical biotechnology companies is also
fueling the growth in the Asia-Pacific region.
The market in the Middle East Africa is likely
to account for the smallest share of the global
cell transverse myelitis market. Check For
Discount https//www.marketresearchfuture.com/che
ck-discount/6490
4
Transverse Myelitis Market
Segmentation The global transverse myelitis
market has been segmented into diagnosis,
treatment, end user, and region. The global
market, by diagnosis, has been segmented into
magnetic resonance imaging (MRI), lumbar
puncture, blood tests, and others. The global
market, on the basis of treatment, has been
segmented into intravenous steroids, plasma
exchange therapy, antiviral medication, pain
medications, physical therapy, occupational
therapy, psychotherapy, and others. The pain
medication has been further segmented into
chronic pain medication and nerve pain
medication. The chronic pain segment has been
further segmented into acetaminophen, ibuprofen,
and naproxen sodium. The nerve pain medication
has been segmented into sertraline, gabapentin,
and pregabalin. On the basis of end user, the
global market has been segmented into hospitals
clinics, diagnostic centers, and others. Key
Players Medtronic, Inc., B. Braun Melsungen AG,
Fresenius Kabi AG, Baxter International, Inc.,
Amgen Inc., Johnson Johnson Consumer Inc.,
Bayer AG, Pfizer, Inc., Cerus Corporation,
Haemonetics Corporation, GlaxoSmithKline, and
Bristol-Myers-Squibb are some prominent players
operating in the market.
5
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
6
(No Transcript)
Write a Comment
User Comments (0)